UPDATED Apr 23, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NEWBRY | kr3.39 | -3.1% | -39.7% | kr82.2m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
CALTX | kr100.40 | -0.1% | -22.2% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$14.25 | 3.1% | -35.5% | US$2.2b | US$29.75 | PE173.8x | E50.8% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$146.07 | 0.5% | -26.0% | US$18.5b | US$220.00 | PS10.1x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$4.58 | -1.3% | -11.6% | US$191.7m | US$19.00 | PS7x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.19 | -2.1% | 70.3% | US$218.7m | US$8.50 | PS2.7x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.98 | -4.3% | -36.3% | US$231.7m | US$26.06 | PS4.6x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
CAI | AU$0.13 | 8.3% | -36.6% | AU$91.3m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
A067310 | ₩26,450.00 | -8.5% | 68.3% | ₩1.3t | ₩36,000.00 | PS1.3x | E66.0% | 0.2% | Semiconductors | ||
688711 | CN¥26.26 | 1.9% | -60.1% | CN¥3.9b | n/a | PE34.8x | E49.6% | 0.05% | Semiconductors | ||
300286 | CN¥18.70 | 2.9% | -46.5% | CN¥3.8b | CN¥30.92 | PE19.6x | E24.3% | 1.6% | Capital Goods | ||
A211050 | ₩4,900.00 | 0% | 140.0% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
HHR | AU$0.007 | -12.5% | -79.4% | AU$16.9m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
4071 | ر.س222.20 | -1.7% | 81.2% | ر.س11.2b | ر.س275.17 | PE34.7x | E26.1% | 1.0% | Media | ||
KCB | KSh29.80 | 7.0% | -10.8% | KSh95.8b | KSh51.24 | PB0.4x | E26.0% | 0% | Banks | ||
FXPO | UK£0.52 | 18.2% | -53.4% | UK£307.1m | UK£1.40 | PB0.3x | E116.3% | 0% | Materials | ||
SEAPT | kr4.94 | -2.8% | -60.5% | kr1.8b | kr11.57 | PB1x | E54.2% | n/a | Energy | ||
CLBIO | kr10.40 | -9.6% | -7.6% | kr223.5m | kr32.00 | PS6.3x | E71.1% | n/a | Pharmaceuticals & Biotech | ||
FTCI | US$0.42 | 2.4% | -83.8% | US$52.3m | n/a | PB0.8x | E63.1% | n/a | Capital Goods | ||
SONM | US$0.48 | -8.6% | -59.2% | US$20.6m | US$2.00 | PB0.9x | E139.9% | n/a | Tech | ||
300442 | CN¥30.03 | -2.2% | -16.4% | CN¥48.2b | CN¥32.52 | PE29.3x | E28.1% | 1.7% | Software | ||
688390 | CN¥92.01 | -11.1% | -56.5% | CN¥16.5b | CN¥133.61 | PE18.3x | E27.1% | 1.2% | Capital Goods | ||
SOKM | ₺55.95 | -11.0% | 65.9% | ₺33.2b | ₺98.16 | PE7.5x | E26.8% | 0.9% | Consumer Retailing | ||
CABP | UK£1.43 | 15.2% | n/a | UK£362.9m | UK£1.78 | PE15.9x | E34.6% | n/a | Diversified Financials |